BioImagene collaborates with ten new academic medical centers to develop digital pathology solutions

BioImagene, Inc., the leading provider of innovative digital pathology solutions has added ten new academic medical centers to its roster of collaborators during the last quarter. Many of these collaborators have been named "America's Best Hospitals 2010-2011: The Honor Roll" by U.S. News and World Report.

“By partnering with leading-edge institutions in healthcare delivery, BioImagene ensures that its solutions continue to be highly innovative and yet grounded in the reality of clinical practice. Both these traits are crucial for broad-based adoption of digital pathology.”

The list of new collaborators working with BioImagene to develop the next generation of digital pathology solutions, include Arizona Cancer Center, Johns Hopkins Hospital, Massachusetts General Hospital, Rady Children's Hospital in San Diego, Rush University Medical Center, Stanford Hospital & Clinics, University of California San Diego, University of Kansas Medical Center, University of Nebraska and University of Washington.

The scope of the collaborations between researchers and clinicians from these leading academic medical institutions and BioImagene include co-development of new Companion Algorithms for Companion Diagnostics for breast, prostate, lung, gastro-intestinal and liver cancer, and validation of integrated diagnostic workstations to be used by pathologists in clinical practice. The collaborators will use BioImagene's Virtuoso web based application and iScan family of slide scanners as the platform for development and validation of these new clinical applications.

Robert Monroe, M.D., Ph.D., Chief Medical Officer of BioImagene explained, "By partnering with leading-edge institutions in healthcare delivery, BioImagene ensures that its solutions continue to be highly innovative and yet grounded in the reality of clinical practice. Both these traits are crucial for broad-based adoption of digital pathology."

Ajit Singh, Ph.D., Chief Executive Officer of BioImagene stated, "Our success in maintaining a dominant position on the innovation curve depends on working with academic partners. We believe that our collaborations with these prestigious institutions will harness the collective intelligence of thought leaders to the benefit of the entire pathology community."